Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

FDA to Host Webinar on Mandatory Prescriber Education

Posted 9/12/2021

The Food & Drug Administration (FDA)  recognizes that there may be new opportunities to improve prescriber education through the Opioid Analgesic Risk Evaluation and Mitigation Strategy and ensure that the education is being delivered in a way that minimizes the burden on the healthcare...
Read More

NY Job Announcement - Deputy Director, BNE

Posted 9/9/2021

The New York Bureau of Narcotic Enforcement (BNE) is looking for a Deputy Director.  The position is responsible for the administration and oversight of the following programs: New York State's Prescription Drug Monitoring Program, Office Prescription Program, Electronic Prescribing,...
Read More

Upcoming Webinar - Sept. 29, 2021 3-4 M

Posted 9/6/2021

Join the National Association of State Controlled Substances Authorities (NASCSA) September 29, 2021 3-4 pm ET for an exclusive look at our new website being launched as a result of the generous contribution of MDScripts.  Speakers: Theo Antoniou, Chief Technology Officer...
Read More

Biden-Harris Administration Provides Recommendations to Congress

Posted 9/3/2021

On September 2, 2021 Regina LaBelle, Acting Director of National Drug Control Policy, presented to Congress the Biden-Harris Administration?s recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances...
Read More

Connecticut PDMP Changes to take affect Sept 1, 2021

Posted 8/13/2021

This is to inform you of changes to the Connecticut Prescription Monitoring and Reporting System (CPMRS) that will take place on September 1, 2021.

The CPMRS reporting requirements will be adding and modifying some required, situational, and not required fields in the ASAP 4.2A software...
Read More

Alabama PDMP Change to ASAP 4.2b Dec 1, 2021

Posted 8/13/2021

Beginning December 1, 2021, the Alabama Prescription Drug Monitoring Program (PDMP) will be adopting the latest reporting standard from the American Society for Automation in Pharmacy (ASAP). Please read the attached document that contains links to additional information, next steps, and contact...
Read More

Sponsor Spotlight

COMPASS Pathways


COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more https://www.compasspathways.com

All Sponsors